Outset Medical, Inc. Variable Lease, Cost
Outset Medical, Inc. (OM) reported Variable Lease, Cost of $423.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-02-13
- Outset Medical, Inc. variable lease, cost for fiscal 2025 was $423.00K, a 20.51% increase from fiscal 2024.
- Outset Medical, Inc. variable lease, cost for fiscal 2024 was $351.00K, a 19.31% decline from fiscal 2023.
- Outset Medical, Inc. variable lease, cost for fiscal 2023 was $435.00K, a 32.22% increase from fiscal 2022.
- Outset Medical, Inc. variable lease, cost for fiscal 2022 was $329.00K, a 12.27% decline from fiscal 2021.
| Period end | Variable Lease, Cost 12 month |
|---|---|
| 2025-12-31 | $423.00K 10-K · filed 2026-02-13 |
| 2024-12-31 | $351.00K 10-K · filed 2026-02-13 |
| 2023-12-31 | $435.00K 10-K · filed 2026-02-13 |
| 2022-12-31 | $329.00K 10-K · filed 2025-02-28 |
| 2021-12-31 | $375.00K 10-K · filed 2024-02-21 |
| 2020-12-31 | $233.00K 10-K · filed 2023-02-13 |
| 2019-12-31 | $100.00K 10-K · filed 2022-02-23 |
| 2018-12-31 | $97.00K 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |